Investment Report of China Medical Industry, 2000-2008
  • Jul/2008
  • Hard Copy
  • USD $2,300
  • Pages:126
  • Single User License
    (PDF Unprintable)       
  • USD $2,500
  • Code: FW004
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,800
  • Hard Copy + Single User License
  • USD $2,500
      

China is the largest country in the world in terms of population. Its population of 1.3 billion people provides a huge market for the development of China's medical service industry. The existing medical resources are far from being able to satisfy people's demand, which results in the problems to be difficult and expensive to see a doctor. However, China's non-public medical service industry is underdeveloped seriously. So China has put forward the ideas to develop medical and health service system by actively introducing non-public funds, which provides a great opportunity for the development of China's non-public medical service industry.

From Jan. to Nov. 2007, the total industrial output value of China's medical instrument and apparatus manufacturing industry hit CNY51.446 billion, up 21.42% against the same period of the previous year, while the accumulated sales revenue and accumulated profit reached CNY49.32 billion and CNY5.26 billion, up 22.17% and 42.51% year on year respectively. In the next few years, China will surpass Japan and become the second largest medical instrument market in the world. The total output value of China's medical instruments and apparatus industry will reach CNY100 billion in 2010, taking up 5% share in the world's medical instruments and apparatus market.

This report makes an in-depth analysis on all investment projects financed by 18 listed companies, covering medical apparatus producers, medical service providers and pharmaceutical producers with investment in medical instruments, from 2000 to 2008 and also makes summary of investment trends of China's medical industry as well as investment features and investment trends of the listed companies.

The following chart shows that Shanghai has the biggest investment in medical projects by taking up 22.72% share of the national total, followed by Hubei province, Jiangxi province, Beijing and Zhejiang province.

Investment Distribution of China Listed Medical Companies (by Region), 2000-1H2008

 200807243.gif

Resource: ResearchInChina

Among the 18 listed companies, Shanghai Pharmaceutical Co. Ltd. ranks first in terms of investment amount from the year of 2000 to the first half of 2008 with a total amount of CNY2.55 billion, followed by Wuhan Humanwell Hi-tech Industry Co., Ltd. and Chengzhi Shareholding Co., Ltd.

Top 10 Companies in Terms of Investment, 2000-1H2008


 200807244.gif
Resource: ResearchInChina

This report makes an in-depth analysis on all investment projects financed by the 18 listed companies. For example, Shanghai Pharmaceutical Co., Ltd. (600849) is referred in this report.

Investment Distribution of Shanghai Pharmaceutical Co. (by Sector), 2000-2008


 200807245.gif

Resource: ResearchInChina

 

Investment of Shanghai Pharmaceutical Co., 2001-2007Year Investment Amount (CNY million)

200807246.gif

Investment Features of Shanghai Pharmaceutical Co., Ltd

  •  Main Business: production, distribution and retail of traditional Chinese medicine and western medicine; diversification direction: pharmaceutical logistics industry.
  • The company has kept a high investment amount for many years. Its investment hit CNY625 million in 2004, which is the highest record of this company. In the past four years, its investment was mainly financed by non fund raising. Its investment is concentrated in East China.
  • The company is one of the three giants in China's pharmaceutical distribution industry. Medicine distribution is its highlight, covering more than 3,900 hospitals across China with sales of more than CNY9 billion. With the help of its strategy of international development, the company together with SUZUKEN Co., Ltd., a world leader in pharmaceutical distribution, has set up a joint venture engaged in pharmaceutical distribution. It has also signed OEM agreement with American Perrigo Company (NASDAQ: PRGO) regarding seven varieties of products and the commitment of 2.1 billion pieces a year, which is hopeful to reach three billion pieces annually. As for pharmaceutical logistics, the company has built a logistics center with an annual throughput of CNY15 billion.

Note: When you purchase this report, we can update the data to the most recent quarter.

1. Investment Direction of Medical Apparatus & Medical Service Industry 
1.1 Overview of the industry
1.2 Investment Features
1.3 Development Trend

2. Investment Direction of Listed Medical Service Companies
2.1 Investment Projects of Chengzhi Shareholding Co., Ltd. 
2.1.1 Investment Direction
2.1.2 Investment Features
2.2 Investment Projects of Chang An Information Industry (Group) Co., Ltd. 
2.2.1 Investment Direction
2.2.2 Investment Features
2.3 Investment Projects of Beijing Tongche Medical Investment Co., Ltd.
2.3.1 Investment Direction
2.3.2 Investment Features

3. Investment Direction of Listed Medical Instrument Companies
3.1 Investment Projects of Shandong Pharmaceutical Glass Co., Ltd.
3.1.1 Investment Direction
3.1.2 Investment Features
3.2 Investment Projects of Suzhou Well Technology Co., Ltd. 
3.2.1 Investment Direction
3.2.2 Investment Features
3.3 Investment Projects of Beijing Wandong Medical Equipment Co., Ltd.
3.3.1 Investment Direction
3.3.2 Investment Features
3.4 Investment Projects of Shandong Shinva Medical Instrument Co., Ltd. 
3.4.1 Investment Direction
3.4.2 Investment Features
3.5 Investment Projects of Leading S&T Co., Ltd. 
3.5.1 Investment Direction
3.5.2 Investment Features
3.6 Investment Projects of Wuhan Humanwell Hi-tech Industry Co., Ltd. 
3.6.1 Investment Direction
3.6.2 Investment Features
3.7 Investment Projects of Yuyue Medical Equipment Co., Ltd. 
3.7.1 Investment Direction
3.7.2 Investment Features

4. Investment Direction of Listed Pharmaceutical Companies with Investment in Medical Instruments
4.1 Investment Projects of Shanghai Pharmaceutical Co., Ltd.
4.1.1 Investment Direction
4.1.2 Investment Features
4.2 Investment Projects of Zhejiang Zhenyuan Co., Ltd.
4.2.1 Investment Direction
4.2.2 Investment Features
4.3 Investment Projects of Accord Pharmaceutical Co., Ltd.
4.3.1 Investment Direction
4.3.2 Investment Features
4.4 Investment Projects of China National Medicines Corporation Ltd.
4.4.1 Investment Direction
4.4.2 Investment Features
4.5 Investment Projects of Shanghai No.1 Pharmacy Co., Ltd.
4.5.1 Investment Direction
4.5.2 Investment Features
4.6 Investment Projects of Nanjing Pharmaceutical Co., Ltd.
4.6.1 Investment Direction
4.6.2 Investment Features
4.7 Investment Projects of Chongqing Tongjunge Pharmaceutical Factory Co., Ltd.
4.7.1 Investment Direction
4.7.2 Investment Features
4.8 Investment Projects of Hangzhou Huadong Medicine Group Co., Ltd.
4.8.1 Investment Direction
4.8.2 Investment Features
Annual Investment of China Listed Medical Companies, 2000-2008
Investment Distribution of China Listed Medical Firms (by region), 2000-1H2008
Top 10 Regions in Terms of Investment of China Listed Medical Firms, 2000-2008
Investment Distribution of China Listed Medical Firms (by Region), 2000-1H2008
Top 10 Companies in Terms of Investment (by Investment Purpose), 2000-2008
Top 10 Firms in Terms of Investment Distribution (by Purpose), 2000-1H2008
Investment of China Listed Medical Firms by Segmented Industry, 2000-2008
Investment Distribution of Listed Firms by Segmented Industry, 2000-1H2008
Top 10 Companies in Terms of Investment, 2000-1H2008
Investment by Non Fund Raising of China Listed Medical Firms, 1Q2006-2Q2008
Investment by Non Fund Raising of Listed Firms by Region, 1Q2006-2Q2008
Top 5 Regions in Terms of Non Fund Raising Investment, 1Q2006-2Q2008
Top 5 Companies in Terms of Non Fund Raising Investment, 1Q2006-2Q2008
Top 5 Firms in Terms of Non Fund Raising Investment (by Segmented Industry), 
1Q2006-2Q2008
Annual Investment of Chengzhi Shareholding Co., Ltd., 2000-2008 
Chengzhi Investment Distribution by Region, 2000-2008
Chengzhi Investment Distribution by Investment Purpose, 2000-2008
Chengzhi Investment by Main Investment Purpose, 2000-2008
Chengzhi Investment Distribution by Segmented Industry, 2000-2008
Chengzhi Investment by Main Segmented Industry, 2000-2008
Chengzhi Main Investment Projects, 2000-2008
Chengzhi Latest Investment Projects, 2000-2008
Chengzhi Main M&A Projects, 2000-2008
Annual Investment of Chang An Information Industry (Group) Co., 2000-2008
Chang An Investment Distribution by Region, 2000-2008
Chang An Investment Distribution by Investment Purpose, 2000-2008
Chang An Investment by Main Investment Purpose, 2000-2008
Chang An Investment Distribution by Segmented Industry, 2000-2008
Chang An Investment by Main Segment Industry, 2000-2008
Chang An Main Investment Projects, 2000-2008
Chang An Latest Investment Projects, 2000-2008
Chang An Main M&A Projects, 2000-2008
Annual Investment of Beijing Tongche Medical Investment Co., 2000-2008
Beijing Tongche Investment Distribution by Region, 2000-2008
Beijing Tongche Investment Distribution by Investment Purpose, 2000-2008
Beijing Tongche Investment by Main Investment Purpose, 2000-2008
Beijing Tongche Investment Distribution by Segmented Industry, 2000-2008
Beijing Tongche Investment by Main Segmented Industry, 2000-2008
Beijing Tongche Main Investment Projects, 2000-2008
Beijing Tongche Latest Investment Projects, 2000-2008
Beijing Tongche Main M&A Projects, 2000-2008
Annual Investment of Shandong Pharmaceutical Glass Co., Ltd., 2000-2008
SPGC Investment Distribution by Region, 2000-2008
SPGC Investment Distribution by Investment Purpose, 2000-2008
SPGC Investment by Main Investment Purpose, 2000-2008
SPGC Investment Distribution by Segmented Industry, 2000-2008
SPGC Investment by Main Segmented Industry, 2000-2008
SPGC Main Investment Projects, 2000-2008
SPGC Latest Investment Projects, 2000-2008
SPGC Main M&A Projects, 2000-2008
Annual Investment of Suzhou Well Technology Co., Ltd., 2000-2008
Suzhou Well Investment Distribution by Region, 2000-2008
Suzhou Well Investment Distribution by Investment Purpose, 2000-2008
Suzhou Well Investment by Main Investment Purpose, 2000-2008
Suzhou Well Investment Distribution by Segmented Industry, 2000-2008
Suzhou Well Investment by Main Segmented Industry, 2000-2008
Suzhou Well Main Investment Projects, 2000-2008
Suzhou Well Latest Investment Projects, 2000-2008
Suzhou Well Main M&A Projects, 2000-2008
Annual Investment of Beijing Wandong Medical Equipment Co., Ltd., 2000-2008
Wandong Medical Investment Distribution by Region, 2000-2008
Wandong Medical Investment Distribution by Investment Purpose, 2000-2008
Wandong Medical Investment by Main Investment Purpose, 2000-2008
Wandong Medical Investment Distribution by Segmented Industry, 2000-2008
Wandong Medical Investment by Main Segmented Industry, 2000-2008
Wandong Medical Main Investment Projects, 2000-2008
Wandong Medical Latest Investment Projects, 2000-2008
Wandong Medical Main M&A Projects, 2000-2008
Annual Investment of Shandong Shinva Medical Instrument Co., Ltd., 2000-2008
Shinva Medical Investment Distribution by Region, 2000-2008
Shinva Medical Investment Distribution by Investment Purpose, 2000-2008
Shinva Medical Investment by Main Investment Purpose, 2000-2008
Shinva Medical Investment Distribution by Segmented Industry, 2000-2008
Shinva Medical Investment by Main Segmented Industry, 2000-2008
Shinva Medical Main Investment Projects, 2000-2008
Shinva Medical Latest Investment Projects, 2000-2008
Shinva Medical Main M&A Projects, 2000-2008
Annual Investment of Leading S&T Co., Ltd., 2000-2008
Leading S&T Investment Distribution by Region, 2000-2008
Leading S&T Investment Distribution by Investment Purpose, 2000-2008
Leading S&T Investment by Main Investment Purpose, 2000-2008
Leading S&T Investment Distribution by Segmented Industry, 2000-2008
Leading S&T Investment by Main Segmented Industry, 2000-2008
Leading S&T Main Investment Projects, 2000-2008
Leading S&T Latest Investment Projects, 2000-2008
Leading S&T Main M&A Projects, 2000-2008

China Blood Product Industry Report, 2020-2027

With the adjustment in the catalog of medicines covered by national medical insurance system, the scope and reimbursement ratio of almost all blood products for clinical use grow tremendously, which h...

China Medical Robot Industry Report, 2020-2026

Medical robot is the most promising segment of service robot market. By one estimate, globally 7,200 units of medical robots were sold and valued at $2.58 billion in 2019, compared with 5,100 units (u...

China In Vitro Diagnostic (IVD) Industry Report, 2019-2025

In vitro diagnosis (IVD) as a good way to make a rapid and definite diagnosis of diseases early, plays an increasingly crucial role in clinical medicine and related medical research fields. China’s IV...

China Aged Care Industry Report, 2019-2025

China’s society has aged before it gets rich. By the end of 2018, people aged over 60 had numbered 249.5 million in the country, or 17.9% of the total population, of which those aged over 65 were 167 ...

China Dental Industry Report, 2019-2025

Nowadays, the Chinese people have a growing awareness of oral health and healthy behaviors. 60.1% of residents have knowledge about oral health; 24.1% of 5-year-old children and 31.9% of 12-year-old c...

China Hospital Industry Report,2019-2025

The people’s growing awareness of health care and the acceleration of population aging have brought prosperity to China’s hospital industry. As of February 2019, there had been a total of 33,000 hospi...

China Dental Industry Report, 2017-2021

As living standards continue to improve and the awareness of oral health grows, consumers’ demand for dental services has kept increasing and the dental industry in China has witnessed robust developm...

China Interferon Industry Report, 2016-2021

Interferon is mainly used for the treatment of hepatitis B, hepatitis C, multiple sclerosis, condyloma acuminatum and other diseases. Wherein, IFN-α is mainly suitable for curing hepatitis B and hepat...

China Hospital Industry Report,2016-2020

In recent years, "Opinions on Promoting the Development of Health Service Industry" and other related policies, the people’s growing awareness of health care and the acceleration of population aging h...

China Aged Care Industry Report, 2016-2020

China entered the aging society early in 1999. By the end of 2015, China’s population aged over 60 reached 222 million and the old-age dependency ratio 13.9%. By 2020, China’s population aged over 60 ...

China Medical Robotics Industry Report, 2016-2020

Medical robotics can be used in surgery, rescue, transport, care, rehabilitation, dispensing and so on for the sick and wounded. Especially, surgical, rehabilitation and dispensing robots are the R &a...

China Dental Industry Report, 2016-2020

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental apparatus (equipments and consumables), dental medical services, etc. With ...

China Medical Imaging Diagnosis Industry Report, 2015-2019

Against the background of a surge in social demand, handsome profit and the favorable opportunity brought by health care reform, the medical imaging industry, especially medical imaging equipment indu...

China Heparin Industry Report, 2015-2018

As the world's largest heparin API producer and exporter, China seizes about 80% share of the global heparin API market. After the explosive growth in 2008-2010, the stagnant international market and ...

Global and China Stem Cell Industry Report, 2015-2018

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Currently, stem cells are used to treat hund...

China Hospital Industry Report, 2015-2018

Stimulated by the demand, the number of hospitals in China rose from 21,979 in 2011 to 26,479 at the end of May 2015, an increase of 4,500 in total. Among them, public hospitals showed an overall decl...

China Independent Clinical Laboratory Industry Report, 2015-2018

The independent clinical laboratory originated from the U.S. and is relatively mature in developed countries/regions like North America, Europe, and Japan, whose independent clinical laboratory market...

China Medical Robot Industry Report, 2014-2018

Medical robots can be applied to surgeries, rescue, transport, nursing and rehabilitation of the sick and wounded. Wherein, surgery and rehabilitation robots are two striking market segments. Due to ...

2005- www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号